Neptune Technologies preclinical data

In healthy rats, human equivalent dosing with 1 g/day of Acasti Pharma Inc.'s CaPre long-chain omega-3 phospholipids for 2 months increased total levels of the cardioprotective omega-3 fatty acids eic...